Search

Your search keyword '"J. Hernando"' showing total 452 results

Search Constraints

Start Over You searched for: Author "J. Hernando" Remove constraint Author: "J. Hernando"
452 results on '"J. Hernando"'

Search Results

1. SITE CALIBRATION WITH PROJ AND WKT2

2. Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin

3. Exploring the sequence-function space of microbial fucosidases

4. Estado Vital de la Materia. Su origen, su evolución y su futuro.

5. Profesor Luis López de Mesa. Reminiscencias

6. Ouabaina como Hormona

7. La Profesión Médica y la Socialización de la Medicina

8. Superficie Específica y Estado Vital de la Materia

9. 'Reflexiones sobre la contracción prosténica'

11. Estudios de patología quirúrgica. Anotaciones sobre la importancia de la coagulación y el tiempo de sangría en las hemorragias.

12. Estudios sobre la etiología y patogenia de la epilepsia II

13. Electrocardiograma normal en Bogotá y su relación con los signos electrocardiográficos de anoxemia

15. Sobre la excitabilidad directa del músculo estriado por descargas ritmicas de condensadores

16. Sobre una contracción rítmica hallada en el músculo gastronemio de la rana durante un tétanos perfecto

17. Reflexiones sobre la causa de las manifestaciones esenciales de la vida

19. Coronavirus disease 2019 in patients with neuroendocrine neoplasms

22. Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus

23. Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%?

24. 1645O Durvalumab (D) plus tremelimumab (T) for the treatment of patients with progressive, refractory advanced thyroid carcinoma: The DUTHY (GETNE-T1812) trial

25. Clinical and Translational Challenges in Thyroid Cancer

26. A method to measure the damping introduced by linear guides in large milling machines

27. Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252] (European Journal of Cancer (2021) 154(246-252) (S0959804921004044), (10.1016/j.ejca.2021.06.029))

28. External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU Study

31. 3D-Printed Liquid Cell Resonator with Piezoelectric Actuation for In-Line Density-Viscosity Measurements

32. Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report

33. 1659TiP A Spanish observational study for MOLecular characterization of THYroid carcinoma: MOLTHY Project – TTCC-2020-02

34. LBA45 Randomized open label phase III study comparing the efficacy and safety of everolimus followed by chemotherapy (CT) with streptozotocin (STZ)-5FU upon progression or the reverse sequence, in advanced progressive panNETs: The SEQTOR study (GETNE 1206)

35. 496MO Final overall survival results from the NICE-NEC trial (GETNE-T1913): A phase II study of nivolumab and platinum-doublet chemotherapy (CT) in untreated advanced G3 neuroendocrine neoplasms (NENs) of gastroenteropancreatic (GEP) or unknown (UK) origin

36. 332P Impact of the COVID-19 pandemic in the early-onset colorectal cancer (EOCRC)

37. Recent developments in the use of glyconanoparticles and related quantum dots for the detection of lectins, viruses, bacteria and cancer cells

38. Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252]

39. P-69 Anal squamous cell carcinoma (ASCC) outcomes in clinical practice: From localized to metastatic setting

40. P-149 Impact of COVID-19 pandemic and total neoadjuvant therapy (TNT) implementation in pathological complete response (pCR) rates in patients (pts) with locally advanced rectal cancer (LARC)

41. Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)

42. Piezoelectric MEMS Linear Motor for Nanopositioning Applications

43. 1099MO Durvalumab plus tremelimumab influence on response to subsequent treatments in patients with neuroendocrine neoplasms (NENs) of gastroenteropancreatic and lung origins: Results from the phase II DUNE trial (GETNE 1601)

44. 1107P Durvalumab plus tremelimumab in patients with grade 3 neuroendocrine neoplasms of gastroenteropancreatic origin: Updated results from the multicenter phase II DUNE trial (GETNE 1601)

45. 1098O Nivolumab plus platinum-doublet chemotherapy as first-line therapy in unresectable, locally advanced or metastatic G3 neuroendocrine Neoplasms (NENs) of the gastroenteropancreatic (GEP) tract or unknown (UK) origin: Preliminary results from the phase II NICE-NEC trial (GETNE T1913)

46. 1110P COVID-19 pandemic impact on healthcare professionals treating patients with neuroendocrine tumors (NET): An international NET CONNECT survey

47. 575TiP Cabozantinib plus atezolizumab in advanced and progressive neoplasms of the endocrine system: A multicohort phase II trial (CABATEN trial / GETNE-T1914)

48. 461P Molecular tumor profiling and matched molecular targeted treatment in metastatic young-onset colorectal cancer (YOCR)

49. Comparative Study of Traveling and Standing Wave-Based Locomotion of Legged Bidirectional Miniature Piezoelectric Robots

Catalog

Books, media, physical & digital resources